4//SEC Filing
FOEHR MATTHEW W 4
Accession 0000950170-25-053867
CIK 0001607678other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:26 PM ET
Size
6.4 KB
Accession
0000950170-25-053867
Insider Transaction Report
Form 4
FOEHR MATTHEW W
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2025-04-11$8.00/sh+20,786$166,288→ 132,036 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-04-11−20,786→ 0 totalExercise: $8.00From: 2016-05-26Exp: 2025-04-28→ Common Stock (20,786 underlying)
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001237556
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:26 PM ET
- Size
- 6.4 KB